The PCORT Advisory Committee is chaired by Dr. G. Scott Gazelle, co-chaired by Dr. Jane Weeks of the Dana-Farber Cancer Institute and composed of leaders of the major specialties and disciplines relevant to Cancer Outcomes Research.

Each member of the Advisory Committee is responsible for identifying and matching trainees with mentors, and for facilitating the implementation of committee policies at their respective institutions and departments.

G. Scott Gazelle, M.D., M.P.H., Ph.D. (Chair); Director, MGH Institute for Technology Assessment, Director, Partners Radiology, Professor in the Department of Health Policy and Management, HSPH, and Professor of Radiology, HMS

Jane C. Weeks, M.D., M.Sc.(Co-Chair); Chief, DFCI Division of Population Science, and Director, DFCI Center for Outcomes and Policy Research, Professor of Medicine, HMS, and Professor in the Department of Health Policy and Management, HSPH

Jose Baselga, M.D., Ph.D., Chief of Hematology/Oncology, MGH, Associate Director, MGH Cancer Center, and Professor, Department of Medicine, HMS

Thomas J. Brady, M.D.; Director of Radiology Research, MGH, and Lawrence Lampson Robbins Professor of Radiology, HMS; Program Leader of Cardiovascular Disease at the Center for Integration of Medicine and Innovative Technology

E. Francis Cook, Sc.D.; Co-Director, Harvard Program in Clinical Effectiveness, Professor of Epidemiology, HSPH, and Professor of Medicine, HMS

Steven Joffe, M.D., M.P.H.;  Associate Professor, Department of Pediatrics, Harvard Medical School, Director, Ethics Program, Catalyst, Harvard Medical School, Pediatric Oncology, Dana-Farber Cancer Institute, Attending Physician, Children’s Hospital Boston

Ann S. LaCasce, M.D.; Director, Ambulatory Services for Hematologic Malignancies, Dana-Farber Cancer Institute, Assistant Professor of Medicine, Harvard Medical School

Joseph P. Newhouse, Ph.D.; Director, Harvard University Ph.D. Program in Health Policy, Director of the Division of Health Policy Research and Education, Chair of Committee on Higher Degrees in Health Policy, and John D. MacArthur Professor of Health Policy and Management, Harvard University

Holly Prigerson, Ph.D.; Director, Center for Psycho-oncology & Palliative Care Research, Dana-Farber Cancer Institute, and Associate Professor of Psychiatry, Harvard Medical School

Kenneth K. Tanabe, M.D.; Chief, Division of Surgical Oncology, MGH, Deputy and Clinical Director, MGH Cancer Center, and Associate Professor of Surgery, HMS

Milton C. Weinstein, Ph.D.; Director, Harvard Program for Economic Evaluation of Medical Technologies, Henry J. Kaiser Professor of Health Policy and Management and Biostatistics, HSPH, and Professor of Medicine, HMS

Winfred W. Williams, M.D.; Director, MGH Multicultural Affairs Office, Director, Interventional Nephrology, MGH, Board of Trustees of MGH Institute of Health Professions and Assistant Professor of Medicine, HMS

 The senior faculty on the Advisory Committee have a distinguished record of training basic, clinical, outcomes, health services, and health policy researchers, many of whom now hold leadership positions at major academic centers throughout the Unites States, Canada, and Europe.